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This multicenter study aimed to investigate prescribing patterns of drugs at different levels of health 
care delivery in university-affiliated outpatient clinics located in eight cities in the South and Midwest 
of Brazil. All prescriptions collected were analyzed for various items, including WHO prescribing 
indicators. A total of 2,411 prescriptions were analyzed, and 469 drugs were identified. The number 
of drugs prescribed per encounter, the frequency of polypharmacy, and the percentage of encounters 
with at least one injection or antibiotic prescribed were higher in centers providing primary health care 
services, compared to those where this type of care is not provided. Most drugs (86.1%) were prescribed 
by generic name. In centers with primary health care services, drug availability was higher, drugs 
included in the National and Municipal Lists of Essential Medicines were more frequently prescribed, 
and patients were given more instructions. However, warnings and non-pharmacological measures were 
less frequently recommended. This study reveals trends in drug prescribing at different levels of health 
care delivery in university-affiliated outpatient clinics and indicates possible areas for improvement in 
prescribing practices.
Keywords: Medicines/rational use. Medicines/prescription. Health Care/quality indicators. Pharmacy/
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Este estudo multicêntrico teve como objetivo investigar o padrão de prescrição de medicamentos para 
pacientes ambulatoriais atendidos em serviços de saúde vinculados a universidades com diferentes níveis 
de atenção, em oito cidades do sul e centro-oeste do Brasil. As prescrições coletadas foram submetidas 
à análise de diversos itens, incluindo os indicadores de prescrição propostos pela OMS. No total, 2.411 
prescrições foram analisadas e 469 medicamentos foram identificados. O número de medicamentos 
prescritos por consulta, a frequência de polifarmácia e a porcentagem de consultas com pelo menos 
um medicamento injetável ou um antimicrobiano prescrito foram maiores em centros de saúde que 
ofereciam cuidados de atenção básica, em comparação com aqueles que não dispunham desse tipo de 
atendimento. A maioria dos medicamentos foi prescrita pelo nome genérico (86,1%). Em unidades com 
cuidados de atenção básica, a acessibilidade foi maior, a prescrição de medicamentos presentes nas Listas 
Nacional e Municipais de Medicamentos Essenciais foi mais frequente e instruções foram fornecidas 
aos pacientes mais comumente. Entretanto, advertências e medidas não farmacológicas foram indicadas 
com menor frequência. Este estudo revela tendências de prescrição de medicamentos em serviços de 
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saúde ligados a universidades, com diferentes níveis de atenção, e indica possíveis áreas de melhoria 
na prática da prescrição.
Unitermos: Medicamentos/uso racional. Medicamentos/prescrição. Assistência à Saúde/indicadores de 
qualidade. Farmácia/serviços comunitários.
INTRODUCTION
The World Health Organization (WHO) suggests 
a set of drug use indicators that has proven useful in the 
investigation of drug prescribing patterns in health care 
facilities (WHO, 1993). Prescribing indicators have been 
used in several studies, showing problems in the pattern 
of drug prescribing in different regions of the world 
(Mahfouz et al., 1997; Nikfar et al., 2005; Sharif et al., 
2008; Vallano et al., 2004). These studies provide data 
to be used in future strategies aiming to promote rational 
drug use.
Prescriptions are a legal document holding the 
prescribing physician and the dispensing pharmacist 
responsible for all drugs that are prescribed and 
dispensed (Sharif et al, 2008). In accordance with the 
Brazilian health regulations (Brasil, 1973), a medication 
order should carry several items, such as name and 
address of the patient and name, address, medical license 
number and signature of the prescriber. The presence 
of these and other data aims at a more rational use of 
drugs, minimizing drug-related problems and improving 
treatment outcomes.
Several studies have assessed patterns of drug use 
practices in the primary health care setting using WHO 
prescribing indicators (Colombo et al., 2004; Mahfouz 
et al., 1997; Nikfar et al., 2005; Oliveira et al., 2009; 
Santos, Nitrini, 2004; Sharif et al., 2008; Vallano et al., 
2004). However, it is also important to assess the drug use 
situation in health facilities that provide more complex 
health services. Although specific indicators have not been 
described for these services, WHO prescribing indicators 
for primary care may be a helpful tool for such work in 
secondary and tertiary care settings.
Institutions providing primary, secondary and 
tertiary care are often affiliated with universities, and 
a previous study suggested that prescribing routines 
experienced by medical students/interns in these 
environments are to be repeated later in the course of their 
professional lives (Heineck et al., 2000).
Therefore, the objective of this study was to 
investigate prescribing patterns at different levels of health 
care delivery in university-affiliated outpatient clinics 
located in the South and Midwest regions of Brazil.
METHODS
This cross-sectional and multicenter study was 
conducted at university-affiliated outpatient clinics 
located in eight cities in the South and Midwest of Brazil. 
The cities have different population sizes, as follows: 
less than 100,000 inhabitants (Lajeado and Tubarão), 
between 100,000 and 200,000 inhabitants (Passo Fundo 
and Dourados), between 300,000 and 500,000 inhabitants 
(Caxias do Sul and Joinville), and more than 500,000 
inhabitants (Campo Grande and Porto Alegre).
Description of research sites
According to the national registry of health 
institutions of the Brazilian Ministry of Health (Brasil, 
2011), all eight centers participating in this study were 
classified as providing secondary care services (availability 
of medical specialists and expert health professionals in 
specific areas, such as endocrinologists and cardiologists, 
and more advanced technological resources to support 
diagnosis and treatment). Six of these centers also 
delivered primary care services within their facilities 
(accounting for 81% of all prescriptions analyzed). Two 
centers also provided tertiary (but not primary) care and 
accounted for 19% of the prescriptions analyzed. The 
criteria for inclusion of outpatient clinics were: (1) being 
affiliated with the Federal University of Rio Grande do 
Sul (UFRGS) as a research partner, (2) being located in 
municipalities of different sizes, categorized according 
to the number of inhabitants, (3) offering internships for 
undergraduate and/or graduate students in the health area 
(including residency programs), who should have access to 
different prescribing patterns. A detailed description of the 
characteristics of the municipalities and outpatient clinics 
participating in this study has been published elsewhere 
(Dal Pizzol et al., 2010).
Sampling
Data were collected over a 12-month period in 
each research site, during the years of 2006, 2007 and 
2008. All prescriptions issued to adult outpatients were 
included. We established a minimum of 24 interviews per 
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month at each research site, which resulted in a minimum 
sample of 288 prescriptions per municipality over 12 
months. Participants were recruited by convenience 
sampling. Monthly data collection was performed on three 
randomly chosen days of the same week of the month. 
If the estimated number of patients was not reached 
(8 patients/day), an additional day was randomly chosen 
in the following week. If, at any time, the additional day 
fell on an already chosen day, lots would be drawn again 
until the overlap was eliminated.
Data collection and analysis
Patients were approached at the outpatient clinic or 
the pharmacy and invited to participate immediately after 
the consultation. A specific questionnaire was completed 
for each patient who received a prescription. The research 
team was previously trained to conduct the interview and 
collect data.
WHO prescribing indicators (WHO, 1993) were 
analyzed, including number of drugs per encounter 
(per prescription), percentage of encounters with at 
least one injection or antibiotic prescribed, frequency 
of polypharmacy (defined as encounters with five or 
more drugs prescribed), percentage of drugs prescribed 
by generic name, percentage of drugs prescribed 
belonging to the 14th WHO Model List (WHO, 2005), 
to the Brazilian National List of Essential Medicines 
(RENAME) (Brasil, 2002), and to the local List of 
Essential Medicines from each city participating in the 
study. The list of antibiotics included in the analysis 
was based on the WHO antimicrobial classification for 
prescribing indicators (WHO, 1993). We also analyzed 
the percentage of different drugs prescribed, using the 
Anatomical Therapeutic Chemical (ATC) classification, 
and the number of drugs available in the same facility of 
the consultation.
We evaluated the percentage of medical orders 
in accordance with the Brazilian health regulations. 
Important items of prescriptions (such as dosage form, 
dose, route of administration, interval between doses, 
and treatment duration) and provision of additional 
written information, including non-pharmacological 
measures, were also considered. We also analyzed whether 
patients received instructions and warnings about the 
use of the drugs prescribed and collected information on 
whom dispensed the medication. Instructions included 
information on how, when and for how long the drug 
should be used, how the product should be stored and what 
to do with the unused product. Warnings corresponded 
to the description of precautions, drug interactions, and 
how to recognize adverse drug reactions and what to do 
about them.
Data were entered into a database developed using 
EpiData 3.1 and analyzed using the Statistical Package for 
the Social Sciences (SPSS) for Windows, version 15.0. 
For analysis purposes, the different levels of health care 
delivery were divided into two groups – centers with and 
without primary health care services. Data were expressed 
as absolute frequency and percentage, mean and standard 
deviation (SD). Associations between patients’ age groups 
and number of drugs prescribed or number of antibiotics 
prescribed per encounter were analyzed using the chi-
square test with adjusted standardized residuals. The 
Student t test was used to assess the statistical significance 
between means. A P-value <0.05 was considered to be 
statistically significant.
Ethical aspects
The study protocol was approved by the Institutional 
Review Boards of all centers involved in the study. Written 
informed consent was obtained from all participants prior 
to their inclusion in the study.
RESULTS
A total of 2,411 prescriptions were analyzed. Most 
patients were female (70.4%), with a mean age of 50.8 
years (SD, 16.5; range, 17–94 years). Of the total sample, 
21% were elderly patients (≥65 years of age) and 11.3% 
were illiterate. Among the elderly, 24.4% reported being 
illiterate. Among those who had some level of formal 
education, 63.9% attended only primary school (until 
the eighth grade), 18% attended high school, and 6.8% 
attended university.
Although patients’ mean age was lower in centers 
with primary health care services (50.4±16.4 vs. 
52.3±17.3 years; Student t test, P = 0.038), there was no 
statistically significant difference in the percentage of 
elderly patients when the levels of health care delivery 
were compared (20.6% in centers with vs. 23.5% in 
centers without primary care; chi-square test with adjusted 
standardized residuals, P = 0.092).
Results concerning WHO prescribing indicators 
(WHO, 1993) are shown in Table I. Five patients were 
prescribed 10 or more drugs per encounter. Two of them 
were prescribed 13 drugs, which was the maximum 
number of drugs prescribed in a consultation in this study. 
The number of drugs per encounter, the frequency 
of polypharmacy, and the percentage of encounters with 
at least one injection or antibiotic prescribed were higher 
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in centers with primary health care services, compared 
to those where this type of care is not provided (Table I).
All injections were prescribed at centers with 
primary health care services (Table I). The agents most 
commonly prescribed were insulin and insulin analogues 
(36.9%), medroxyprogesterone (9.2%), and benzathine 
benzylpenicillin (7.7%), which together accounted for 
53.8% of all injections prescribed.
Most antibiotics were prescribed in centers with 
primary health care services (Table I). Only 29 patients 
(1.2%) received more than one antimicrobial agent. Forty-
five different agents were prescribed, accounting for 6.1% 
of all drugs prescribed. The most commonly prescribed 
antibiotics were amoxicillin (19.8%), metronidazole 
(10.3%), cephalexin (7.8%), sulfamethoxazole and 
trimethoprim (7.8%), and norfloxacin (6.3%).
Comparing centers with and without primary health 
care services, the overall frequency of prescription of 
drugs by generic name and of drugs included in the WHO 
Model List was similar between groups. However, in 
centers with primary health care services, drug availability 
was higher (P = 0.001), and drugs included in the National 
and Municipal Lists of Essential Medicines were more 
frequently prescribed (P = 0.001) (Table I).
When analyzing the indicators of rational use of 
medicines according to age group, there was a significant 
association between the number of drugs per encounter 
and patient age (chi-square test with adjusted standardized 
residuals, P = 0.001). In the group aged <65 years, most 
patients were prescribed only one drug. Conversely, 
polypharmacy was statistically more common among 
elderly patients (15.9% vs. 6.5% in younger patients). In 
this study, patients aged ≥65 years were prescribed a mean 
of 2.6 drugs (SD, 1.8; range, 1–9), which was significantly 
different from the value obtained for younger patients – 
mean of 2.1 drugs (SD, 1.4; range, 1–13) (Student t test, 
P = 0.001).
There was also a significant association between 
the percentage of antibiotics prescribed and patient age 
(chi-square test with adjusted standardized residuals, 
P=0.001). Younger patients were more frequently 
prescribed antimicrobial agents than the elderly (14.9% 
vs. 6.7%). Twenty-seven patients aged <65 years were 
prescribed two or more antibiotics (maximum of four), 
while the maximum number of antibiotics received by 
elderly patients was two (used by two patients).
Young patients were prescribed 35 different 
antimicrobial agents. The most commonly prescribed 
antibiotics were amoxicillin (23.6%), cephalexin 
(14.6%), metronidazole (14.2%), sulfamethoxazole and 
trimethoprim (9.4%), norfloxacin (6.9%), ampicillin 
(5.2%), and azithromycin (5.2%), accounting for 79.1% 
TABLE I - Indicators of rational use of medicines proposed by the World Health Organization (WHO), as assessed in outpatient 
clinics in eight Brazilian cities* (2006-2008), considering the different levels of health care delivery – centers with or without 
primary health care services
Prescribing indicator Total sample 
(n=2,411)
With primary care 
(n=1,956)
Without primary care 
(n=455)
Number of drugs per encounter (mean ± SD)a  
(range)
2.2 ± 1.5 
(1 – 13)
2.3 ± 1.6  
(1 – 13)
1.6 ± 1.0 b 
(1 – 7)
Encounters with only one drug prescribed 42% 38.2% 58% c
Encounters with five or more drugs prescribed (polypharmacy) 8.5% 9.9% 2.6% c
Encounters with at least one injection prescribed 2.5% 3.1% 0% c
Encounters with at least one antibiotic prescribed 13.1% 15.5% 3.1% c
Drugs prescribed by generic name 86.1% 86.4% 84.4%
Drugs included in the WHO Model List 62.3% 62.1% 63.1%
Drugs included in the National List of Essential Medicines 73.7% 81.0% 52.6% c
Drugs included in the local List of Essential Medicines 77.4% 81.4% 54.8% c
Drugs available in the same facility of the consultation 65.9% 68.1% 53.7% c
SD = standard deviation. 
a Median of 2 drugs per encounter (25th–75th percentile, 1–3) in the total sample and centers with primary health care services; 
median of 1 (25th–75th percentile, 1–2) in centers without primary health care services.
b Statistically different from centers with primary health care services; Student t test, P = 0.001.
c Statistically different from centers with primary health care services; chi-square test with adjusted standardized residuals, P = 0.001.
*Lajeado, Tubarão, Passo Fundo, Dourados, Caxias do Sul, Joinville, Campo Grande, and Porto Alegre.
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TABLE II - Legal aspects of the prescription – specific information on the prescribing physician and patient, as assessed in outpatient 
clinics in eight Brazilian cities* (2006-2008), considering the different levels of health care delivery – centers with or without 
primary health care services
Information
Prescriptions containing information
Total sample (%)
(n=2,411)
With primary care (%)
(n=1,956)
Without primary care (%)
(n=455)
Physician
Name 94.8 95.0 93.8
Signature 97.6 97.4 98.5
Address 54.2 63.0 16.3a
License number 91.7 92.2 89.5
Patient
Name 98.8 99.2 97.1
Address 3.9 3.9 4.0
Prescription 
Date 94.5 94.5 94.5
a Statistically different from centers with primary health care services; chi-square test with adjusted standardized residuals, P = 0.001.
*Lajeado, Tubarão, Passo Fundo, Dourados, Caxias do Sul, Joinville, Campo Grande, and Porto Alegre.
of all antibiotic prescriptions in these patients. Elderly 
patients were prescribed 13 antimicrobial agents. The 
most common ones were amoxicillin (25%), cephalexin 
(15.6%), norfloxacin (12.5%), sulfamethoxazole 
and trimethoprim (9.4%), and ciprofloxacin (9.4%), 
accounting for 71.9% of all antibiotic prescriptions among 
the elderly. 
Concerning the legal aspects of the prescription, 
information on the prescriber and patient was deficient 
(Table II). In 99.2% of prescriptions, at least one item 
was incomplete and/or missing. This pattern was similar 
between centers with and without primary health care 
services. The address of the prescribing physician was 
the most commonly provided item, and was found in a 
significantly higher number of prescriptions in centers 
with primary health care services (chi-square test with 
adjusted standardized residuals, P = 0.001).
Data on important items of prescriptions and 
provision of additional information are shown in Table 
III. The oral route was indicated in 83.2% of all cases 
(83.5% in centers with and 75.3% in centers without 
primary health care services; chi-square test with adjusted 
TABLE III - Important items of the prescription, as assessed in outpatient clinics in eight Brazilian cities* (2006-2008), considering 
the different levels of health care delivery – centers with or without primary health care services
Information
Prescriptions containing information
Total sample (%)
(n=2,411)
With primary care (%)
(n=1,956)
Without primary care (%)
(n=455)
Dosage form 97.6 97.5 98.4
Dose 78.0 76.0 89.1
Route of administration 92.3 91.4 97.4
Interval between doses 96.7 96.5 98.0
Treatment duration 91.6 91.7 91.5
Instructions 92.9 94.5 86.2a
Warnings 6.9 5.2 14.1a
Non-pharmacological measures 3.3 2.8 5.7a
a Statistically different from centers with primary health care services; chi-square test with adjusted standardized residuals, P ≤ 0.003.
*Lajeado, Tubarão, Passo Fundo, Dourados, Caxias do Sul, Joinville, Campo Grande, and Porto Alegre.
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standardized residuals, P ≤ 0.001). Topical use was 
recommended for 3.9% of all drugs prescribed (3.5% in 
centers with and 13.8% in centers without primary health 
care services; chi-square test with adjusted standardized 
residuals, P ≤ 0.001). 
Information on the drug dosage regimen was 
considered complete only in 74.1% of all drugs prescribed. 
The lack of an item on the dosage regimen was significantly 
more common in prescriptions from centers with primary 
health care services (68.9% vs. 99.9% in centers without 
primary health care services; chi-square test with adjusted 
standardized residuals, P ≤ 0.001).
While instructions were more frequently found 
in prescriptions from centers with primary health care 
services, non-pharmacological measures (including 
homemade nasal saline solution, dressings, sitz bath, 
application of heat, eyelid hygiene using baby shampoo, 
use of condoms during sexual intercourse, and food 
suggestions) and warnings were more commonly reported 
on prescriptions from centers without primary health 
care services (chi-square test with adjusted standardized 
residuals, P ≤ 0.003). The prescriber was the only source 
of information in most cases (70.1%).
All prescriptions analyzed were handwritten, and 
a total of 469 different drugs were identified during 
our analysis. In only 0.6% of cases drugs could not be 
identified due to an illegible prescription or absence of the 
drug from the list of products registered with the Brazilian 
National Health Surveillance Agency (ANVISA, Brazil).
The most commonly prescribed therapeutic 
classes of drugs were analgesics (9%), drugs targeting 
the renin-angiotensin-system (8.4%), diuretics (8.2%), 
psychoanaleptics (6.4%), anti-inflammatory and 
antirheumatic drugs (5.2%), and antithrombotic agents 
TABLE IV - Drugs most frequently prescribed in outpatient clinics in eight Brazilian cities* (2006-2008), considering the different 
levels of health care delivery – centers with or without primary health care services
Drugs (ATC)
Percentage of drugs prescribed
Total sample 
(n=2,411)
With primary care 
(n=1,956)
Without primary care 
(n=455)
Hydrochlorothiazide (C03AA03) 6.4 7.3 1.2
Acetaminophen (N02BE01) 6.1 6.6 2.9
Captopril (C09AA01) 5.9 6.6 1.6
Aspirin (B01AC06) 3.9 4.6 1.6
Amitriptyline (N06AA09) 3.0 2.3 7.1
Ibuprofen (M01AE01) 2.8 3.2 0.1
Propranolol (C07AA05) 2.2 2.6 0
Simvastatin (C10AA01) 2.2 2.3 1.4
Fluoxetine (N06AB03) 2.2 1.2 8.8
Enalapril (C09AA02) 2.2 2.5 0
Omeprazole (A02BC01) 2.2 2.2 1.8
Metformin (A10BA02) 2.1 2.4 0.7
Metamizole (Dipyrone) (N02BB02) 2.1 2.3 0.5
Diosmin (C05CA03) 1.3 0 8.8
Other therapeutic products (V03AX) a 0.8 0 5.5
Warfarin (B01AA03) 0.6 0 3.8
Carbamazepine (N03AF01) 1.3 0.1 3.2
Fenoterol (R03AK03) b 0.4 0 2.7
Budesonide (R03BA02) 0.4 0 2.6
Biperiden (N04AA02) 0.4 0 2.1
ATC = Anatomical Therapeutic Chemical classification.
a Some were herbal products. 
b And other drugs for obstructive airway diseases.
*Lajeado, Tubarão, Passo Fundo, Dourados, Caxias do Sul, Joinville, Campo Grande, and Porto Alegre.
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(5.2%). Antimicrobial agents for systemic use were found 
in 4.3% of prescriptions. 
In centers with primary health care services, the 
five most commonly prescribed drugs were agents for the 
treatment of cardiovascular disease (hydrochlorothiazide, 
captopril, and aspirin – as an antithrombotic agent) and 
for the management of pain and inflammatory conditions 
(acetaminophen and ibuprofen) (Table IV). All drugs 
were included in the 14th WHO Model List (WHO, 
2005), the Brazilian National List of Essential Medicines 
(RENAME) (Brasil, 2002), and the Municipal List of 
Essential Medicines. In centers without primary health 
care services, the profile of the prescription varied greatly. 
Antidepressants, antiepileptics and antithrombotic agents 
– fluoxetine, amitriptyline, carbamazepine, and warfarin 
– were the most commonly prescribed drugs, and they 
were included in the local and National Lists of Essential 
Medicines. However, diosmin and other therapeutic 
agents, such as herbal products, were not considered 
essential medicines.
DISCUSSION
The aim of this study was to investigate the 
prescribing pattern of drugs used by outpatients attending 
university-affiliated public health clinics that provide 
different levels of health care. Significant differences were 
observed when centers with and without primary health 
care services were compared.
The number of drugs per encounter was higher in 
centers providing primary care (2.3 vs. 1.6 in centers 
without primary care). However, these values were close 
to the limit of two drugs per encounter recommended by 
WHO (WHO, 1993) and similar to or lower than figures 
reported for other countries or Brazilian cities, ranging 
from 1.44 to 3.6 (Colombo et al., 2004; Guyon et al., 1994; 
Mahfouz et al., 1997; Nikfar et al., 2005; Santos, Nitrini, 
2004; Vallano et al., 2004).
The frequency of polypharmacy was also higher in 
centers with primary health care services. One possible 
explanation is that, in tertiary care, patients seek expert 
advice from a health professional for very specific 
complaints, resulting in a tailored prescription and 
reducing the likelihood of use of various drugs. In primary 
care, however, the patients are often considered as a whole 
resulting in a greater number of drugs prescribed. 
Concomitant use of several drugs may be justified 
in the treatment of multiple chronic diseases (Gallagher et 
al., 2007; Shi et al., 2008). In this study, among the most 
frequently prescribed drugs, there were those used in the 
treatment of cardiovascular diseases, such as hypertension, 
with an estimated prevalence of 22.3 to 43.9% in Brazil 
(IV Brazilian Guidelines in Arterial Hypertension Work 
Groups, 2004; Gus et al., 2004), and metabolic syndrome, 
with a prevalence of 30% in a Brazilian study (Oliveira 
et al., 2006). Four of these drugs – hydrochlorothiazide, 
captopril, enalapril, and propranolol – represent drugs 
of choice in the treatment of these diseases. Similarly, 
low-dose aspirin is indicated for the prevention and 
treatment of cardiovascular disease and ischemic events, 
and simvastatin is recommended for the treatment of 
dyslipidemia (Harrington et al., 2008; Ito et al., 2012; 
Lansberg et al., 2012; Vandvik et al., 2012). Moreover, 
metformin was prescribed, a drug used to treat diabetes, 
with an estimated prevalence of 10.1% in Brazil (Toscano 
et al., 2008). Acetaminophen and ibuprofen, drugs with 
recognized efficacy and safety and commonly used in 
clinical practice, were also frequently prescribed for pain 
and inflammatory conditions. Other studies (Córdoba et 
al., 1999; Mahfouz et al., 1997; Vallano et al., 2004) have 
already reported similar results.
All drugs mentioned here are considered essential 
medicines according to the national and local lists. 
Therefore, our data suggest a rational use of medicines. 
However, we draw attention to the frequent prescription 
of amitriptyline and fluoxetine, used in the treatment 
of depression, and dipyrone, a drug banned in several 
countries, but legally marketed in Brazil.
Concerning the presence of injections on the 
prescription, there is no WHO recommendation as to a 
limit for this indicator in primary care, but the percentage 
observed – 2.5% in the total sample and 3.1% in centers 
with primary health care services – was similar to the 
rate of 3% reported by Vallano et al. (2004). Three 
drugs accounted for 54% of cases using this dosage 
form: insulin – which is only available in the injectable 
form; benzylpenicillin – which, although an alternative 
therapy is available, should be preferably used in the 
injectable form to preserve the broad-spectrum agents; and 
medroxyprogesterone injection – which has been regarded 
as rational because it promotes better treatment adherence 
and consequently improves effectiveness. These three 
drugs have been part of the National List of Essential 
Medicines. The fact that these agents are recommended 
for diseases usually treated in centers providing primary 
health care may explain the percentage of injections 
prescribed at this level of health care in the present study.
The number of encounters with at least one antibiotic 
prescribed was higher in centers with primary care. This 
finding could be attributed to the fact that patients with 
manifestations of infectious diseases primarily seek a 
general practitioner and not a specialist. It is important 
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to note that the most frequently prescribed antibiotics – 
amoxicillin, metronidazole, cephalexin, sulfamethoxazole 
and trimethoprim, and norfloxacin – are indicated for 
prevalent infections treated in centers providing primary 
health care services, such as otitis media, sinusitis, 
and infections of the respiratory, genitourinary and 
gastrointestinal tracts. 
WHO does not establish a limit for the number 
of encounters with at least one antibiotic prescribed in 
the primary care setting. The percentages observed in 
the centers with different levels of health care services, 
ranging from 3.1 to 15.5%, were remarkably lower than 
the limit of 20% suggested by Cosendey et al. (2000), 
and below the rates reported in Andorra (29%) (Vallano 
et al., 2004), Bangladesh (25%) (Guyon et al., 1994), 
and Saudi Arabia (56.2%) (Mahfouz et al., 1997). 
Differences observed among the studies are probably 
due to the epidemiological profile of infections in the 
different geographic areas. Factors such as prevalence of 
specific types of pathogens in the community, adequacy 
of infrastructure in the geographic area analyzed (e.g., 
water supply, sewage system, and hygiene habits), and 
health care accessibility may lead to different infection 
prevalence rates and distinct antibiotic prescribing patterns 
(Gavazzi et al., 2004). Guyon et al. (1994) assessed the 
use of medicines for six diseases commonly found in the 
outpatient clinics in rural Bangladesh – watery diarrhea, 
dysentery with blood, helminthiasis, pneumonia, acute 
respiratory tract infections, and scabies. Mahfouz et al. 
(1997) and Vallano et al. (2004) conducted studies in the 
Asir region (southwestern Saudi Arabia) and Andorra 
(a small European country), respectively, but failed to 
provide a description of specific diseases. In the first 
study, data were collected from the health information 
system of primary health care centers, and in the second 
study, prescriptions from different medical specialties 
(including General Practice, Pediatrics, Cardiology, 
Pulmonology, Gynecology, and Ophthalmology) were 
analyzed. The differences observed among the studies 
could be attributed to methodological aspects. Unlike 
the investigations by Guyon et al. (1994), Mahfouz et al. 
(1997) and Vallano et al. (2004), in this study the health 
centers were affiliated with universities, which may have 
influenced the prescribing patterns, reducing the use of 
antimicrobials.
Nevertheless, the low rate of antibiotic prescription 
in the present study does not indicate that the prescribing 
pattern in Brazil is better than in other countries, since we 
did not analyze the criteria justifying the clinical indication 
for the antibiotic order. However, when analyzing the most 
frequently prescribed agents, four of them – amoxicillin, 
metronidazole, cephalexin, and sulfamethoxazole and 
trimethoprim – were present in the local and National 
Lists of Essential Medicines and accounted for 45.7% of 
all antibiotics prescribed, suggesting a rational prescribing 
pattern.
In this study, young patients were more frequently 
prescribed antibiotics (14.9% vs. 6.7% in the elderly), 
which is in agreement with the results reported by 
Vallano et al. (2004) (25% for young patients vs. 16.5% 
for the elderly). The impossibility of establishing a 
relationship between the prescription and the infectious 
disease diagnosed limits data analysis. However, the 
prevalence of specific infections in these age groups 
may explain the observed differences. Beta-lactam 
antibiotics, fluoroquinolones and the combination of 
sulfonamide and trimethoprim accounted for 79.1% of 
all antimicrobial prescriptions in the elderly, which is 
consistent with the most common infections reported 
in this age group – pneumonia, urinary tract infections, 
and skin and soft tissue infections (Gavazzi et al., 2004; 
Bellmann-Weiler, Weiss, 2009). Moreover, drugs such 
as ampicillin, metronidazole and azithromycin, which 
were prescribed for many young patients (but have 
other clinical indications), showed a percentage of zero 
prescription among the elderly (data not shown). Another 
possible explanation is related to differences in disease 
severity, since the clinical presentation of infection may 
be different in the elderly. Signs and symptoms may 
be more subtle, atypical, or absent in this age group, 
thus hindering or delaying diagnosis and treatment 
(Bellmann-Weiler, Weiss, 2009; Herring et al., 2007). 
Additionally, infections in elderly patients are generally 
more severe and associated with an increased risk of death 
(Bellmann-Weiler, Weiss, 2009), which may lead them 
to seek care in emergency departments directly, instead 
of ambulatory services. Studies from different countries 
have reported that elderly patients with infectious diseases 
are hospitalized more often and have a higher mortality 
rate than younger patients (Gavazzi et al., 2004). Finally, 
the higher prevalence of non-rational prescription of 
antibiotics for infections in patients aged <65 years is a 
factor that should also be considered, since two or more 
antimicrobial agents were prescribed for 27 individuals 
in this age group (vs. only two elderly patients). Further 
studies are warranted to investigate differences in the 
epidemiology of infections in these two age groups and 
specific antimicrobial prescribing patterns.
In this study, drugs included in the Municipal 
and National Lists of Essential Medicines were more 
frequently prescribed (77.4% and 73.7%, respectively) 
than those in the WHO Model List (62.3%). This result 
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is consistent with the idea that national and local lists 
are compiled considering local epidemiological data and 
needs related to the level of health care. It is worth noting 
that, based on these data, the municipalities appeared 
to be using the list proposed nationally or, at least, they 
were following the same parameters for drug selection 
(Dal Pizzol et al., 2010). However, higher percentages 
were observed in other countries – 99.3% in the Asia 
region, Saudi Arabia (Mahfouz et al., 1997), and 85% in 
Bangladesh (Guyon et al., 1994). Thus, it is reasonable 
to assume that it is still possible to improve adherence to 
essential drugs lists by prescribers.
Interestingly, the high percentage of essential drugs 
prescribed was not maintained in centers providing only 
secondary and tertiary care, which suggests that the 
presence of primary health care services may influence 
the general prescribing pattern. Moreover, it is known 
that essential medicines do not meet all the care needs of 
the population. Thus, some drugs may be appropriately 
prescribed in secondary and tertiary care centers, 
even though they are not present in the list of essential 
medicines. However, this does not exclude the possibility 
of “non-rational prescription”, which may be supported by 
the fact that diosmin and other therapeutic products were 
among the most commonly prescribed items in centers 
without primary health care services.
Also interesting is the finding that the lower 
percentage of essential medicines prescribed in secondary 
and tertiary care centers did not determine a lower use 
of the generic denomination. The percentage of drugs 
prescribed by generic name was similar among the centers 
providing different levels of health care. Although the 
percentage observed in the total sample (86.1%) was 
higher than those reported in Bangladesh (78%) (Guyon 
et al., 1994), in Saudi Arabia (2.9%) (Mahfouz et al., 
1997), and in Andorra (6%) (Vallano et al., 2004), WHO 
suggests prescribing 100% of drugs by generic name in 
the primary health setting. Likewise, the Brazilian health 
regulations require the use of the generic denomination 
while prescribing in the Public Health System (Brasil, 
2001). One possible explanation for these discrepancies is 
the prescription of drugs that are not listed on the essential 
medicines lists, which could lead to the use of brand names. 
Another possibility is the lack of knowledge about the 
essential medicines lists and current legislation. Marketing 
strategies in the pharmaceutical industry, emphasizing 
the brand name of products, may also contribute to this 
finding. However, regardless of the level of health care 
delivery, prescribing drugs by generic name may reduce 
duplicity, improve access to medicines and, consequently, 
increase patient compliance with drug therapy and disease 
control. This practice may be improved by emphasizing to 
medical students the importance of properly prescribing 
drugs by their generic names.
In the present study, several prescribed drugs 
(34.1%) were not available in the same facility of the 
consultation, and this percentage increased to 46.3% in 
centers without primary health care services. Although 
drug availability is not a prescribing indicator, access 
to medicines is an indicator of rational use of drugs and 
is a key priority (WHO, 2008). From the consumer’s 
point of view, access to medicines means that drugs can 
be obtained within reasonable travel distance from the 
health facility (Nikfar et al., 2005). Lack of knowledge 
or prescribers’ non-adherence to the List of Essential 
Medicines available in the municipality may contribute 
to this finding. Moreover, these data may indicate that 
local essential medicines lists are not properly considering 
the therapeutic needs of the health centers. Also, drug 
shortage may influence the choice of the prescriber for 
“non-essential medicines”. Other aspects related to the 
municipal pharmaceutical care, such as presence of a 
pharmacy within the health center, may also affect the 
success of a program of essential medicines. Aiming to 
increase adherence to local Essential Medicines Lists, 
it is important that the selected drugs are periodically 
updated by a multidisciplinary committee, that the list is 
appropriately disclosed to prescribers, and that a regular 
supply of medicines is maintained in the pharmacy (Dal 
Pizzol et al., 2010).
Most patients (93%) received written instructions for 
the use of prescribed medicines, but only a few received 
warnings and information on non-pharmacological 
measures (7% and 3%, respectively). The prescription is 
the main source of information about the pharmacological 
treatment and, according to WHO, medical orders should 
contain, at least, the following items: drug effects, 
warnings, instructions for use, and adverse drug reactions 
(Organización Mundial de la Salud, 1998). Several health 
professionals provide only verbal information, which 
may not be effective, because patients tend to forget 
approximately half of the information received (Ley, 
1982).
Overall, data resulting from the analysis of prescribing 
indicators in this study suggest a rational use of medicines. 
This may be attributed to the facilities where the data were 
collected – university-affiliated health centers. This is a 
very important feature as these places are well recognized 
by their role in the education of future health professionals. 
Heineck et al. (2000) showed that Brazilian prescribers 
appointed learning during internship and health care 
routines as the main sources of knowledge about drug 
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prescription. Conversely, the results clearly demonstrated 
the need for considerable improvement in prescribing 
practices even in these university-affiliated centers.
A limitation of the study is that drug prescribing 
patterns were assessed in health centers within a university 
setting, and the data cannot be extrapolated to centers 
without this characteristic context.
We concluded that drug prescribing practices should 
be improved regardless of the level of health care delivery. 
It is necessary to implement institutional guidelines in 
order to achieve more appropriate prescribing patterns, 
to promote prescription based on the list of essential 
medicines, and to highlight the importance of these 
practices in medical school and continuing medical 
education for a more rational and safer use of medicines.
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